SynthesisDermatology and therapy2026

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

Paola Facheris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.